News
ReShape Lifesciences Tweets 'Will #GLP1 medications replace #weightloss #surgery? According to ReShape CEO, Paul Hickey, via @InvestingCom, #GLP1s are a very attractive tool to fight #obesity. However, our ReShape Lap-Band® is safe and less invasive'
3 Apr 24
News
Reshape Lifesciences FY23 Sales $8.678M Miss $8.904M Estimate
1 Apr 24
Earnings, Earnings Misses, News
ReShape Lifesciences Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 FLEX
22 Feb 24
Biotech, News, General
ReShape Lifesciences Posts On X "There Is Growing Consumer Awareness Of Medical #weightloss Generated By GLP-1s. Reshape Lifesciences Is Tapping Into This Market With Our Full Portfolio Of Weight Loss And Wellness Solutions"
20 Feb 24
Biotech, News, General
Press releases
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
1 Apr 24
Earnings, Press Releases
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
28 Mar 24
News, Health Care, Legal, Press Releases
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
4 Mar 24
Health Care, Press Releases, General
ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
22 Feb 24
Press Releases
ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
24 Jan 24
Health Care, Press Releases, General